213 related articles for article (PubMed ID: 21984806)
1. TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow.
Tsuji S; Cortesão C; Bram RJ; Platt JL; Cascalho M
Blood; 2011 Nov; 118(22):5832-9. PubMed ID: 21984806
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation.
Castigli E; Wilson SA; Elkhal A; Ozcan E; Garibyan L; Geha RS
J Allergy Clin Immunol; 2007 Oct; 120(4):885-91. PubMed ID: 17689597
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival.
Ou X; Xu S; Lam KP
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15401-6. PubMed ID: 22949644
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
Banday VS; Thyagarajan R; Sundström M; Lejon K
Immunology; 2016 Nov; 149(3):297-305. PubMed ID: 27444337
[TBL] [Abstract][Full Text] [Related]
6. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency.
Lee JJ; Jabara HH; Garibyan L; Rauter I; Sannikova T; Dillon SR; Bram R; Geha RS
J Allergy Clin Immunol; 2010 Dec; 126(6):1234-41.e2. PubMed ID: 20889194
[TBL] [Abstract][Full Text] [Related]
7. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
8. Differential induction of plasma cells by isoforms of human TACI.
Garcia-Carmona Y; Cols M; Ting AT; Radigan L; Yuk FJ; Zhang L; Cerutti A; Cunningham-Rundles C
Blood; 2015 Mar; 125(11):1749-58. PubMed ID: 25631768
[TBL] [Abstract][Full Text] [Related]
9. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
[TBL] [Abstract][Full Text] [Related]
10. To switch or not to switch--the opposing roles of TACI in terminal B cell differentiation.
Salzer U; Jennings S; Grimbacher B
Eur J Immunol; 2007 Jan; 37(1):17-20. PubMed ID: 17171762
[TBL] [Abstract][Full Text] [Related]
11. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
[TBL] [Abstract][Full Text] [Related]
12. Effect of TACI signaling on humoral immunity and autoimmune diseases.
Zhang Y; Li J; Zhang YM; Zhang XM; Tao J
J Immunol Res; 2015; 2015():247426. PubMed ID: 25866827
[TBL] [Abstract][Full Text] [Related]
13. TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens.
Mantchev GT; Cortesão CS; Rebrovich M; Cascalho M; Bram RJ
J Immunol; 2007 Aug; 179(4):2282-8. PubMed ID: 17675489
[TBL] [Abstract][Full Text] [Related]
14. TACI and endogenous APRIL in B cell maturation.
Garcia-Carmona Y; Fribourg M; Sowa A; Cerutti A; Cunningham-Rundles C
Clin Immunol; 2023 Aug; 253():109689. PubMed ID: 37422057
[TBL] [Abstract][Full Text] [Related]
15. The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice.
Bacchelli C; Buckland KF; Buckridge S; Salzer U; Schneider P; Thrasher AJ; Gaspar HB
J Allergy Clin Immunol; 2011 May; 127(5):1253-9.e13. PubMed ID: 21458042
[TBL] [Abstract][Full Text] [Related]
16. TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen.
Tsuji S; Stein L; Kamada N; Nuñez G; Bram R; Vallance BA; Sousa AE; Platt JL; Cascalho M
J Clin Invest; 2014 Nov; 124(11):4857-66. PubMed ID: 25271628
[TBL] [Abstract][Full Text] [Related]
17. IL-10 production in murine IgM
Suzuki-Yamazaki N; Yanobu-Takanashi R; Okamura T; Takaki S
Eur J Immunol; 2017 Mar; 47(3):493-503. PubMed ID: 28012163
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.
Ozcan E; Rauter I; Garibyan L; Dillon SR; Geha RS
J Allergy Clin Immunol; 2011 Sep; 128(3):601-9.e1-4. PubMed ID: 21741080
[TBL] [Abstract][Full Text] [Related]
19. TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo.
Diaz-de-Durana Y; Mantchev GT; Bram RJ; Franco A
Blood; 2006 Jan; 107(2):594-601. PubMed ID: 16195331
[TBL] [Abstract][Full Text] [Related]
20. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
Tran NL; Schneider P; Santiago-Raber ML
Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
